Simulation analysis of formycin 5?-monophosphate analog substrates in the ricin A-chain active site

1995 ◽  
Vol 9 (3) ◽  
pp. 226-236 ◽  
Author(s):  
Mark A. Olson ◽  
John P. Scovill ◽  
Dallas C. Hack
1991 ◽  
Vol 230 (1-2) ◽  
pp. 81-90 ◽  
Author(s):  
Jane H. Gould ◽  
Martin R. Hartley ◽  
Philip C. Welsh ◽  
Deborah K. Hoshizaki ◽  
Arthur Frankel ◽  
...  

Biochemistry ◽  
1996 ◽  
Vol 35 (34) ◽  
pp. 11098-11103 ◽  
Author(s):  
Philip J. Day ◽  
Stephen R. Ernst ◽  
Arthur E. Frankel ◽  
Arthur F. Monzingo ◽  
John M. Pascal ◽  
...  

2003 ◽  
Vol 271 (1) ◽  
pp. 153-162 ◽  
Author(s):  
Catherine J. Marsden ◽  
Vilmos Fülöp ◽  
Philip J. Day ◽  
J. Michael Lord

Toxins ◽  
2018 ◽  
Vol 10 (9) ◽  
pp. 371 ◽  
Author(s):  
Xiao-Ping Li ◽  
Jennifer Kahn ◽  
Nilgun Tumer

Ricin A chain (RTA) depurinates the sarcin/ricin loop (SRL) by interacting with the C-termini of the ribosomal P stalk. The ribosome interaction site and the active site are located on opposite faces of RTA. The interaction with P proteins allows RTA to depurinate the SRL on the ribosome at physiological pH with an extremely high activity by orienting the active site towards the SRL. Therefore, if an inhibitor disrupts RTA–ribosome interaction by binding to the ribosome binding site of RTA, it should inhibit the depurination activity. To test this model, we synthesized peptides mimicking the last 3 to 11 amino acids of P proteins and examined their interaction with wild-type RTA and ribosome binding mutants by Biacore. We measured the inhibitory activity of these peptides on RTA-mediated depurination of yeast and rat liver ribosomes. We found that the peptides interacted with the ribosome binding site of RTA and inhibited depurination activity by disrupting RTA–ribosome interactions. The shortest peptide that could interact with RTA and inhibit its activity was four amino acids in length. RTA activity was inhibited by disrupting its interaction with the P stalk without targeting the active site, establishing the ribosome binding site as a new target for inhibitor discovery.


2013 ◽  
Vol 288 (42) ◽  
pp. 30270-30284 ◽  
Author(s):  
Xiao-Ping Li ◽  
Peter C. Kahn ◽  
Jennifer Nielsen Kahn ◽  
Przemysław Grela ◽  
Nilgun E. Tumer

1992 ◽  
Vol 227 (4) ◽  
pp. 1136-1145 ◽  
Author(s):  
Arthur F. Monzingo ◽  
Jon D. Robertus

Sign in / Sign up

Export Citation Format

Share Document